Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ACR-2316 |
| Synonyms | |
| Therapy Description |
ACR-2316 inhibits WEE1 and PKMYT1, which potentially inhibits cell cycle progression, cancer cell proliferation, and tumor growth (Cancer Res (2024) 84 (6_Supplement): 1977). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ACR-2316 | ACR2316|ACR 2316 | PKMYT1 Inhibitor 4 WEE1 Inhibitor 8 | ACR-2316 inhibits WEE1 and PKMYT1, which potentially inhibits cell cycle progression, cancer cell proliferation, and tumor growth (Cancer Res (2024) 84 (6_Supplement): 1977). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06667141 | Phase I | ACR-2316 | Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors | Recruiting | USA | 0 |